Predictors of Treatment Outcomes among Pediatric Patients Hospitalized with Pneumonia in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

Table 4

Predictors of treatment outcomes among children treated for pneumonia at the pediatric ward of Tikur Anbessa Specialized Hospital from February 2017 to February 2018, Addis Ababa, Ethiopia.

Variable		Treatment outcome		Corollary (95% CI)	AOR (95% CI)
		Good	Poor
Age	<1 month	1	1	1	1
	1 month–1 year	121	9	0.074 (0.004–1.3)	4.4 (0.015–13.2)
	1 year–3 years	45	1	0.022 (0.001–.67)	0.77 (0.01–73.2)
	3 years–6 years	14	2	0.143 (0.006–3.3)	0.27 (0.003–26.8)
	>6 years	10	2	0.300 (0.014–6.4)	1.2 (0.05–27.7)
Weight (kg)	1–5 kg	19	4	1	1
	6–10 kg	132	6	0.216 (0.056–0.84)	1.139 (0.11–118.3)
	11–15 kg	28	2	0.339 (0.056–2.041)	0.2.43 (0.03–17.6)
	>16 kg	12	4	1.58 (0.332–7.56)	0.396 (0.013–12.4)
Antibiotic administered	Crystalline penicillin	107	4	1	1
	Ampicillin + gentamycin	11	1	2.43 (0.25–23.7)	1.83 (0.072–46.57)
	Ceftriaxone	43	3	1.86 (0.40–8.6)	1.61 (0.24–10.96)
	Ceftriaxone + gentamycin	14	1	1.91 (0.19–18.3)	0.887 (0.08–9.4)
	Ceftriaxone + azithromycin	7	2	7.6 (1.8–49.2)	0.086 (0.01–0.83)
	Vancomycin	4	3	20.1 (3.32–121.3)	0.123 (0.011–1.35)
	Ceftriaxone + metronidazole	5	2	10.7 (1.6–72.9)	0.241 (0.024–2.4)
Hospital stay (days)	≤3	25	2	1	1
	4–5	77	4	0.65 (0.112–3.76)	0.828 (0.137–5.01
	6–7	61	2	0.41 (0.055–31)	3.73 (0.59–23.4
	≥8	28	8	3.57 (1.9–18.4)	14.30 (1.35–51.1)